Importantly, this transcriptional reprogramming occurs in HT-29 cells, a model of apoptosis resistance [23], highlighting Beclin 1 suppression as a potential strategy to sensitise tumours that are otherwise refractory to caspase-dependent death [24]. The gene discussed is BECN1; the disease is neoplasm.